Annual Interest Expense
N/A
31 December 2023
Summary:
Inhibikase Therapeutics annual interest expense is not available.IKT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
30 September 2024
Summary:
Inhibikase Therapeutics quarterly interest expense is not available.IKT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
30 September 2024
Summary:
Inhibikase Therapeutics TTM interest expense is not available.IKT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IKT Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Inhibikase Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $19.90 K(-32.3%) | $200.00(0.0%) | $20.00 K(-25.7%) |
| Sept 2021 | - | $200.00(-97.4%) | $26.90 K(-19.9%) |
| June 2021 | - | $7800.00(-33.9%) | $33.60 K(-0.3%) |
| Mar 2021 | - | $11.80 K(+66.2%) | $33.70 K(+15.0%) |
| Dec 2020 | $29.40 K | $7100.00(+2.9%) | $29.30 K(-2.0%) |
| Sept 2020 | - | $6900.00(-12.7%) | $29.90 K(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $7900.00(+6.8%) | $30.80 K(+8.1%) |
| Mar 2020 | - | $7400.00(-3.9%) | $28.50 K(+14.9%) |
| Dec 2019 | $24.80 K(-18.2%) | $7700.00(-1.3%) | $24.80 K(+45.0%) |
| Sept 2019 | - | $7800.00(+39.3%) | $17.10 K(+83.9%) |
| June 2019 | - | $5600.00(+51.4%) | $9300.00(+151.4%) |
| Mar 2019 | - | $3700.00 | $3700.00 |
| Dec 2018 | $30.30 K | - | - |
FAQ
- What is the all time high annual interest expense for Inhibikase Therapeutics?
- What is the all time high quarterly interest expense for Inhibikase Therapeutics?
- What is the all time high TTM interest expense for Inhibikase Therapeutics?
What is the all time high annual interest expense for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual interest expense is $30.30 K
What is the all time high quarterly interest expense for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly interest expense is $11.80 K
What is the all time high TTM interest expense for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high TTM interest expense is $33.70 K